{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:36:02Z","timestamp":1787697362461,"version":"build-2784847793"},"reference-count":26,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100008615","name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Womens Health (Lond Engl)"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Persistent high-risk human papillomavirus (hrHPV) infection can lead to cervical precancer, with women living with HIV (WLWH) at increased risk due to impaired immune clearance. Thermal ablation (TA) is a low-cost treatment for precancerous lesions, but data on hrHPV persistence after TA among WLWH are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To evaluate overall and channel-specific hrHPV persistence 12\u2009months after TA among women in Lilongwe, Malawi.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Cross-sectional analysis of Malawian women who received TA during and after the PEER trial (prevention of cervical cancer through two HPV-based screen-and-treat implementation models in Malawi).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We analyzed 495 hrHPV-positive women (113 WLWH, 382 without HIV) treated with TA. Self-collected cervicovaginal samples were obtained before treatment and at 12\u2009months post-treatment and tested with the GeneXpert HPV assay, which detects hrHPV across five high-risk genotype channels (P1\u2013P5). Channels P3\u2013P5 were grouped as non-16\/18\/45 hrHPV types (HPV 31, 33, 35, 39, 51, 52, 56, 58, 59, 66, 68). Persistence was defined as the detection of the same channel at both time points. Differences in persistence rates were assessed using Fisher\u2019s exact and Welch\u2019s\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -tests.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      At 12\u2009months post-TA, 35.6% of women were persistently hrHPV-positive. Persistence was higher among WLWH (46.0%) than women without HIV (32.0%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.01). By genotype, persistence was most common for non-16\/18\/45 types (37.7%), followed by HPV16 (28.9%) and HPV18\/45 (18.0%). WLWH had higher persistence of non-16\/18\/45 types (51.8% versus 33.7% in HIV-negatives,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.003), while persistence of HPV16 (35.0% versus 27.1%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.58) and HPV18\/45 (26.3% versus 14.9%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.14) did not differ significantly.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Over one-third of women had persistent hrHPV 12\u2009months after TA, with higher rates among WLWH, primarily for non-16\/18\/45 genotypes. Findings highlight the need for enhanced follow-up and adjunct therapies to improve post-treatment clearance and advance cervical cancer prevention in low-resource settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17455057261428547","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:15:38Z","timestamp":1777029338000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Persistent human papillomavirus after thermal ablation in Malawian women with and without HIV: Implications for risk-based cervical cancer prevention in low- and middle-income countries"],"prefix":"10.1177","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2326-5180","authenticated-orcid":false,"given":"Jessica","family":"Gingles","sequence":"first","affiliation":[{"name":"Division of Global Women\u2019s Health, Department of OB-GYN, The University of North Carolina at Chapel Hill School of Medicine, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2506-8907","authenticated-orcid":false,"given":"Yating","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Gillings School of Global Public Health, The University of North Carolina, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lameck","family":"Chinula","sequence":"additional","affiliation":[{"name":"Division of Global Women\u2019s Health, Department of OB-GYN, The University of North Carolina at Chapel Hill School of Medicine, NC, USA"},{"name":"UNC Project \u2013 Malawi, Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4238-2791","authenticated-orcid":false,"given":"Jennifer H.","family":"Tang","sequence":"additional","affiliation":[{"name":"Division of Global Women\u2019s Health, Department of OB-GYN, The University of North Carolina at Chapel Hill School of Medicine, NC, USA"},{"name":"UNC Project \u2013 Malawi, Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5163-0366","authenticated-orcid":false,"given":"Ivy","family":"Kaliati","sequence":"additional","affiliation":[{"name":"UNC Project \u2013 Malawi, Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3321-7422","authenticated-orcid":false,"given":"Tawonga","family":"Mkochi","sequence":"additional","affiliation":[{"name":"UNC Project \u2013 Malawi, Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizzie","family":"Msowoya","sequence":"additional","affiliation":[{"name":"UNC Project \u2013 Malawi, Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charity","family":"Nakanga","sequence":"additional","affiliation":[{"name":"UNC Project \u2013 Malawi, Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1190-1499","authenticated-orcid":false,"given":"Friday","family":"Saidi","sequence":"additional","affiliation":[{"name":"Division of Global Women\u2019s Health, Department of OB-GYN, The University of North Carolina at Chapel Hill School of Medicine, NC, USA"},{"name":"UNC Project \u2013 Malawi, Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1256-0422","authenticated-orcid":false,"given":"Jennifer S.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Gillings School of Global Public Health, The University of North Carolina, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3655-4721","authenticated-orcid":false,"given":"Chemtai","family":"Mungo","sequence":"additional","affiliation":[{"name":"Division of Global Women\u2019s Health, Department of OB-GYN, The University of North Carolina at Chapel Hill School of Medicine, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32470-X"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2019.1634030"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.045"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-021-00355-6"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30459-9"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.11754"},{"key":"e_1_3_3_8_2","volume-title":"Global strategy to accelerate the elimination of cervical cancer as a public health problem","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. World Health Organization, 2020."},{"key":"e_1_3_3_9_2","volume-title":"Global cancer observatory: cancer today","author":"Ferlay J","year":"2024","unstructured":"Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. International Agency for Research on Cancer, 2024."},{"key":"e_1_3_3_10_2","article-title":"Subnational HIV incidence trends in Malawi: large, heterogeneous declines across space","volume":"2023","author":"Wolock TM","year":"2023","unstructured":"Wolock TM, Flaxman S, Chimpandule T, et al. Subnational HIV incidence trends in Malawi: large, heterogeneous declines across space. medRxiv 2023; 2023: 2023.02.02.23285334.","journal-title":"medRxiv"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30635-7"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43467-2"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34737"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-022-06409-3"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34221"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21696"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35519"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.2683"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-021-00839-7"},{"key":"e_1_3_3_20_2","volume-title":"WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions. World Health Organization, 2019."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27828"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264498"},{"issue":"106","key":"e_1_3_3_24_2","first-page":"348","article-title":"Type-specific incidence, persistence, and factors associated with human papillomavirus infection among female sex workers in West Africa","volume":"2021","author":"Tounkara FK","unstructured":"Tounkara FK, T\u00e9gu\u00e9t\u00e9 I, Gu\u00e9dou FA, et al. Type-specific incidence, persistence, and factors associated with human papillomavirus infection among female sex workers in West Africa. Int J Infect Dis 2021(106): 348\u2013357.","journal-title":"Int J Infect Dis"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2250690"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0316334"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.16093"}],"container-title":["Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17455057261428547","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17455057261428547","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17455057261428547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T08:30:36Z","timestamp":1777710636000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17455057261428547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":26,"alternative-id":["10.1177\/17455057261428547"],"URL":"https:\/\/doi.org\/10.1177\/17455057261428547","relation":{},"ISSN":["1745-5057","1745-5065"],"issn-type":[{"value":"1745-5057","type":"print"},{"value":"1745-5065","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"article-number":"17455057261428547"}}